Trials / Completed
CompletedNCT01265706
Livalo Acute Myocardial Infarction Study (LAMIS)
1-year, Prospective, Randomized, Open-label, Parallel Group Observational Study to Evaluate the Safety and Efficacy of 4mg/Day of Pitavastatin Versus 2mg/Day of Pitavastatin in Acute Myocardial Infarction(AMI)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- JW Pharmaceutical · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is performed to observe the incidence of major cardiovascular events in Korean patients with AMI after giving pitavastatin 2mg and 4mg longer than 1 year.
Conditions
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2014-05-01
- Completion
- 2014-12-01
- First posted
- 2010-12-23
- Last updated
- 2014-12-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01265706. Inclusion in this directory is not an endorsement.